TITLE

Inhouse authorization center to improve reimbursement for outpatient chemotherapy infusions

AUTHOR(S)
Desai, Shetal S.
PUB. DATE
May 2011
SOURCE
American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p828
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. The use of an inhouse authorization center to improve reimbursement for outpatient chemotherapy infusions is described. Summary. Investigation of current processes revealed deficiencies in the coordination of an insurance authorization process at Norris Cancer Hospital, as chemotherapy orders were not always reviewed for third-party payer authorization. Same-day chemotherapy treatment was often provided incident to a secondary oncology consultation, resulting in higher payer denials due to the absence of advanced authorization for treatment. The authorizations conducted by nonclinical hospital personnel were often incomplete and inconsistent with the policies and procedures established by third-party payers. Treatments for off-label indications were deemed experimental by the payers and required extensive documentation and review time by the payer in order to authorize treatment. These requirements were not consistently followed by the hospital facility, causing disruptions in the payment revenue cycle due to a high volume of claim disputes and, consequently, consequently, unpaid claims. A clinically staffed authorization department was created to obtain third-party payer authorizations and serve as a centralized clinical department within the hospital to interface with payers and manufacturer-sponsored patient assistance programs. Within the first year of the center's inception, over $500,000 in drug replacement was recovered through patient assistance programs and a total of $1.4 million was recovered within 2.5 years. The number of disputed claims was also reduced. Conclusion. Implementation of a clinical authorization process and use of manufacturer-driven patient assistance programs led to a reduction of disputed claims from third-party commercial payers and substantial savings in chemotherapy charges from January 2008 through July 2010.
ACCESSION #
60335988

 

Related Articles

  • Hospital earns financial rewards for inpatient MTM services. Traynor, Kate // American Journal of Health-System Pharmacy;5/15/2014, Vol. 71 Issue 10, p774 

    The article discusses the financial benefits gained by Asante Rogue Regional Medical Center in Medford, Oregon from private-payer reimbursement of inpatient medication therapy management (MTM) services provided by pharmacists. Deborah Sanchez, Asante's director of pharmacy practice and...

  • Correcting Misperceptions Related to Chemotherapy Drug Shortages in the United States. Glied, Sherry A. // Journal of Oncology Practice;Mar2015, Vol. 11 Issue 2, following p165 

    A letter to the editor is presented in response to the article "Chemotherapy drug shortages in the United States revisited" by H. Kantarjian in an issue in 2014 is presented.

  • Leveraging data for bundled payments, orthopedics goes first. HOPPSZALLERN, SUZANNA // H&HN: Hospitals & Health Networks;Jun2016, Vol. 90 Issue 6, p16 

    This article discusses what a health system needs to do before entering into a bundled payment arrangement for total hip and knee replacements or cardiac surgery. Topics covered include the need for hospitals to carefully analyze all costs, quality measures and possible complications for the...

  • Reader Questions.  // Oncology & Hematology Coding Alert;Jan2013, Vol. 15 Issue 1, pp6 

    No abstract available.

  • Hospital Readmissions Reduction Program: Implications for pharmacy. GREEN BOESEN, KELLY A.; LEAL, SANDRA; SHEEHAN, VALERIE C.; SOBOLIK, ROBERT // American Journal of Health-System Pharmacy;2/1/2015, Vol. 72 Issue 3, p237 

    The author discusses the effect of the Hospital Readmissions Reduction Program on hospital and strategies used by pharmacy departments to reduce hospital readmission rates. Topics discussed include how the hospital's readmission rate is determined through a discharge data from a minimum of 25...

  • Return on investment of a pharmacy residency training program. Pasek, Peter A.; Stephens, Carolyn // American Journal of Health-System Pharmacy;11/15/2010, Vol. 67 Issue 22, p1952 

    Purpose. The return on investment of pharmacy residency training at a Veterans Affairs hospital was estimated. Methods. The financial costs and benefits associated with one year's training of eight residents were estimated retrospectively. The costs were compared with estimated costs for...

  • The Rising Risk Tide. LARKIN, HOWARD // H&HN: Hospitals & Health Networks;Aug2011, Vol. 85 Issue 8, p22 

    The article discusses health care reform in the U.S. A transition from a volume-based to value-based insurance reimbursement model, the quality and efficiency of value-based purchasing, and the health industry's concerns about accountable care are discussed. Cost-control and accountable-care...

  • Reviewing Revenue Cycle Operations in an Age of Payer Audits. Brzon, Mandie // Revenue Cycle Strategist;Apr2012, Vol. 9 Issue 3, p5 

    The article discusses the need to ensure optimal revenue cycle performance as federal payer and managed care audits, to become more prevalent. Key things that healthcare organizations must keep in mind about areas of revenue cycle that can affect audit outcomes include managing all revenue cycle...

  • Revenue Cycle? More Like a Revenue Rhythm. Stickel, Tom // Revenue Cycle Strategist;Oct2012, Vol. 9 Issue 8, p5 

    The article provides suggestions to revenue cycle leaders to keep revenue cycle going. It is suggested that a steady rhythm must be developed for revenue cycle. To achieve this desired rhythm, revenue cycle leaders should start their morning by meeting the staff; they should review the dashboard...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics